Related Experiment Videos
[Clinical significance and problems of technique in the immunochemical determination of the third complement
Insights
The third complement (C) component C3 determination is crucial for evaluating immunopathology. Accurate C3 measurement requires careful consideration of assay techniques and C3 conversion states to minimize errors in clinical diagnostics.
Area of Science:
- Immunology
- Clinical Chemistry
Context:
- Immunochemical determination of the third complement (C) component C3 is vital for assessing immunopathological conditions.
- Changes in C3 levels are linked to both congenital C deficiencies and acquired diseases, with diminished C3 being particularly significant in acquired conditions.
Purpose:
- To highlight the clinical relevance of C3 determination in immunopathology.
- To discuss the complexities and potential errors in immunochemical C3 measurement, including factors like C3 conversion and assay specificity.
Summary:
- Reduced C3 levels can result from classical or alternative pathway activation, or decreased synthesis.
- Technical factors, such as in vitro sample aging and anti-C3 serum specificity, significantly impact C3 assay accuracy.
- Determining C3 as beta 1 C protein requires a specific standard, while beta 1 A quantitation is simpler but necessitates a lengthy incubation for complete C3 conversion.
Impact:
- Accurate C3 measurement is essential for diagnosing and managing immunopathological diseases.
- Understanding assay limitations can lead to improved diagnostic accuracy and patient care.
- Further research may focus on optimizing C3 assay methods to overcome current challenges, such as the time delay in C3 conversion.
Abstract:
Immunochemical determination of the third complement (C) component C 3 as beta 1 C/beta 1 A protein has found extensive use in the clinical evaluation of immunopathological conditions. C 3 changes are associated with inborn C defects and acquired diseases. In the latter case, diminished C3 levels are of the greatest practical relevance. Reduced C 3 values are not necessarily due to "classical" antibody-mediated C activation, as in immune-complex diseases, but may be caused also by "alternative" pathway activation and decreased C 3 synthesis. In addition, important technique factors have to be considered in the evaluation of immunochemically-determined C 3 values. Since the antigenic pattern of C 3 changes during in vitro ageing, not only the state of conversion of C 3 in the sample and in the reference serum (standard), but above all, the specificity of the anti-C 3-serum plays an important role in critically influencing the total error of the method. In order to avoid this error C 3 can be determined as beta 1 C protein using a beta 1 C standard which is, however, not easily available. On the other hand, beta 1 A quantitation causes less problems since standard sera usually contain C 3 as beta 1 A portein. However, an incubation period of 7 days at + 37 degrees C is necessary for complete C 3 conversion. This undesirable time delay has not yet been satisfactorily overcome by in vitro acceleration of C 3 conversion using different substances.